These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 21317673

  • 1. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R, Guillén-Grima F, Perez-Fernandez N.
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.